PRODUCT

CJC-1295 DAC (2 mg) + Ipamorelin (5 mg) Stack

No short description available.

Quickstart Highlights

This stacked protocol combines CJC-1295 DAC, a long-acting GHRH analog with extended half-life via albumin binding[1], and Ipamorelin, a selective ghrelin-receptor agonist that triggers potent GH pulses with minimal ACTH/cortisol release[2]. Together, these peptides amplify endogenous growth hormone secretion and IGF-1 signaling through complementary mechanisms[3].

CJC-1295 DAC: Add 2.0 mL bacteriostatic water → 1.0 mg/mL; inject once weekly.
Ipamorelin: Add 3.0 mL bacteriostatic water → 1.67 mg/mL; inject once daily.
Easy measuring: CJC-1295 DAC: 1 unit = 10 mcg; Ipamorelin: 1 unit ≈ 16.7 mcg on U-100 syringes.
Storage: Lyophilized: ≤−15 °C (5 °F); reconstituted: 2–8 °C (35.6–46.4 °F); use within 3–4 weeks.

Reconstitution

Draw 2.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming or direct stream onto powder.
Gently swirl/roll until fully dissolved (do not shake).
Label with date and refrigerate at 2–8 °C (35.6–46.4 °F) .
Label with date and refrigerate at 2–8 °C (35.6–46.4 °F).

Protocol Overview

Goal:Amplify endogenous GH/IGF-1 secretion through dual GHRH and ghrelin-receptor pathways[3].
Schedule:CJC-1295 DAC once weekly + Ipamorelin once daily for 8–16 weeks.
CJC-1295 DAC Dose:1–2 mg weekly (standard: 1 mg).
Ipamorelin Dose:100–300 mcg daily with gradual titration.
Storage:Lyophilized frozen; reconstituted refrigerated; avoid freeze–thaw cycles.

Dosage Protocols

Timing:Ipamorelin before bed aligns with natural nocturnal GH release[4].
Cycle Length:8–12 weeks standard; extend to 16 weeks if tolerated.

Storage Instructions

Lyophilized:Proper storage preserves peptide integrity and efficacy. Lyophilized (dry powder): Store at ≤−15 °C (5 °F); preferably ≤−50 °C (−58 °F) for long-term storage[5]. Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks[6]. Allow vials to reach room temperature before opening to minimize condensation uptake. Avoid repeated freeze–thaw cycles of reconstituted solutions.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks[6].

Important Notes

Practical considerations for consistency and safety.

Use a new sterile insulin syringe for each injection; dispose in a sharps container.
Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily Ipamorelin doses and weekly CJC-1295 DAC administrations to maintain consistency.
Keep CJC-1295 DAC and Ipamorelin in separate vials; do not pre-mix.

How It Works

CJC-1295 DAC functions as a synthetic GHRH analog that stimulates pituitary GH release. Its Drug Affinity Complex (DAC) moiety binds to serum albumin, extending its half-life to approximately 6–8 days and producing sustained, dose-dependent elevations in GH and IGF-1[1]. Ipamorelin is a selective growth hormone secretagogue that activates the ghrelin receptor (GHSR) to trigger rapid GH pulses without significantly affecting ACTH, cortisol, or prolactin[2]. When combined, these peptides act through complementary pathways—GHRH receptor and ghrelin receptor—to synergistically amplify endogenous GH secretion[3].

Lifestyle Factors

Pair with a balanced, protein-forward diet tailored to individual energy and recovery needs.
Combine resistance training and aerobic activity to support anabolic adaptations.
Prioritize 7–9 hours of quality sleep; GH secretion peaks during deep sleep[4].
Manage stress and avoid chronic caloric restriction, which can blunt GH response.

Injection Technique

Clean the vial stopper and skin with alcohol; allow to dry completely.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[9].
Do not aspirate for subcutaneous injections; inject slowly and steadily[10].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
Limit each injection to ≤1 mL; split larger volumes into separate injections[9].

Benefits and Side Effects

Benefits

Body composition: GH secretagogues have demonstrated improvements in lean mass and reductions in fat mass in clinical studies[7].
Sustained GH/IGF-1 elevation: CJC-1295 DAC produces prolonged elevations lasting 6–11 days per administration[1].
Selectivity: Ipamorelin does not significantly increase cortisol or ACTH at therapeutic doses[2].

Side Effects

Tolerability: Both peptides were well tolerated in human studies, with transient injection-site reactions being the most common adverse effect[8].
Water retention, mild headache, and transient numbness/tingling have been reported with GH-elevating compounds.

CJC-1295 DAC (2 mg) + Ipamorelin (5 mg) Stack

Resources

Categories

Company